|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.50 GBX | +0.46% |
|
-1.14% | +29.64% |
| 07-09 | Spire Healthcare announces further deadline extension for Toscafund | AN |
| 07-09 | Spire Healthcare takeover deadline for Toscafund extended to August 6 | RE |
Company Valuation: Spire Healthcare Group plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,002 | 920.8 | 915.3 | 909.5 | 672 | 867.3 | - | - |
| Change | - | -8.12% | -0.6% | -0.63% | -26.12% | 29.07% | - | - |
| Enterprise Value (EV) 1 | 2,065 | 2,037 | 2,123 | 2,148 | 1,953 | 2,085 | 2,017 | 1,937 |
| Change | - | -1.33% | 4.18% | 1.2% | -9.08% | 6.74% | -3.27% | -3.93% |
| P/E | -104x | 109x | 34.3x | 36.5x | 41.8x | 24.3x | 13.7x | 12.4x |
| PBR | - | 1.25x | 1.24x | 1.22x | 0.9x | 1.37x | 1.28x | 1.18x |
| PEG | - | -1x | 0x | -6.02x | -1.2x | 0x | 0.2x | 1.2x |
| Capitalization / Revenue | 0.91x | 0.77x | 0.67x | 0.6x | 0.43x | 0.54x | 0.51x | 0.49x |
| EV / Revenue | 1.87x | 1.7x | 1.56x | 1.42x | 1.24x | 1.3x | 1.19x | 1.09x |
| EV / EBITDA | 11.6x | 10x | 9.07x | 8.26x | 7.27x | 7.71x | 6.69x | 6.07x |
| EV / EBIT | 25.5x | 19.3x | 16.3x | 14.4x | 13x | 13.9x | 11.3x | 10.7x |
| EV / FCF | 18x | 21.7x | 16.2x | 17.4x | 11.9x | 12.3x | 10.2x | 30.6x |
| FCF Yield | 5.55% | 4.61% | 6.18% | 5.75% | 8.38% | 8.11% | 9.8% | 3.27% |
| Dividend per Share 2 | - | 0.005 | 0.021 | 0.023 | 0.015 | 0.0204 | 0.0454 | 0.0375 |
| Rate of return | - | 0.22% | 0.93% | 1.02% | 0.9% | 0.94% | 2.1% | 1.73% |
| EPS 2 | -0.024 | 0.021 | 0.066 | 0.062 | 0.04 | 0.0892 | 0.1584 | 0.1747 |
| Distribution rate | - | 23.8% | 31.8% | 37.1% | 37.5% | 22.8% | 28.7% | 21.4% |
| Net sales 1 | 1,106 | 1,198 | 1,359 | 1,511 | 1,580 | 1,609 | 1,701 | 1,783 |
| EBITDA 1 | 178.2 | 203.5 | 234 | 260 | 268.6 | 270.5 | 301.4 | 319.4 |
| EBIT 1 | 81.1 | 105.6 | 130.4 | 149.4 | 150.5 | 149.8 | 177.7 | 181.7 |
| Net income 1 | -9.7 | 8.6 | 27.3 | 25.4 | 16.4 | 36.53 | 64.71 | 70.81 |
| Net Debt 1 | 1,063 | 1,117 | 1,207 | 1,239 | 1,281 | 1,217 | 1,149 | 1,070 |
| Reference price 2 | 2.500 | 2.280 | 2.265 | 2.260 | 1.670 | 2.165 | 2.165 | 2.165 |
| Nbr of stocks (in thousands) | 400,862 | 403,868 | 404,099 | 402,440 | 402,371 | 400,598 | - | - |
| Announcement Date | 03/03/22 | 02/03/23 | 29/02/24 | 06/03/25 | 05/03/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 24.27x | 1.3x | 7.71x | 0.94% | 1.16B | ||
| 33.18x | 3.11x | 13.88x | 1.34% | 18.32B | ||
| 66.68x | 5.25x | 35.56x | 0.26% | 13.33B | ||
| 20.57x | 2.96x | 10.52x | 2.02% | 11.45B | ||
| 17.88x | 2.08x | 9.75x | 0.7% | 10.93B | ||
| 23.83x | 1.92x | 15.97x | 0.16% | 9.77B | ||
| 19.01x | 2.78x | 11.43x | 4.19% | 9.36B | ||
| 68.27x | 8.19x | 35.69x | 0.13% | 7.66B | ||
| 31.62x | 0.85x | 7.08x | 2.04% | 6.71B | ||
| 12.78x | 1.11x | 6.75x | 2.04% | 6.9B | ||
| Average | 31.81x | 2.95x | 15.43x | 1.38% | 9.56B | |
| Weighted average by Cap. | 33.37x | 3.20x | 16.68x | 1.35% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SPI Stock
- Valuation Spire Healthcare Group plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















